ZEAL ZEAL Network SE Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg's Top 50 ✓
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
12:10
Mar 06
Abeer Abu Omar Reporter, Bloomberg London Bloomberg Markets
Zealand Pharma shares plunged ~33% (trading in Denmark, implies ADR impact). Their weight loss drug showed only ~10.7% loss over 42 weeks. The weight loss market is a duopoly (Novo/Lilly). To compete, a new entrant needs superior data. Zealand's data is significantly "shorter than rivals," rendering their product commercially unviable in a crowded market. SHORT. The market is pricing out the probability of this drug's success. Potential M&A target for big pharma looking for pipeline assets despite weak data.
ZEAL
08:07
Mar 06
@FirstSquawk
ZEALAND PHARMA SHARES DROP BY RECORD 32% ON OBESITY DRUG DATA
ZEAL

About ZEAL Analyst Coverage

Buzzberg tracks ZEAL (ZEAL Network SE) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked.